A web-based survey on Australian community pharmacists perceptions and practices of generic substitution

Journal of Generic Medicines

Volumn 7, Issue 4, 2010, Pages 342-353

  Chee Ping, Chong ^c   March, Geoff ^a   Clark, Alice ^a   Gilbert, Andrew ^a   Hassali, Mohamed Azmi ^b   Bahari, Mohd Baidi ^b  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^c Universiti Sains Malaysia ^*

Author keywords

community pharmacist; generic medicines; generic substitution; perception; policy

Indexed keywords

GENERIC DRUG;

ARTICLE; AUSTRALIA; BEHAVIOR CHANGE; CHRONIC DISEASE; CONFUSION; EDUCATION PROGRAM; HUMAN; INTERNET; PATIENT ATTITUDE; PHARMACIST ATTITUDE; PRESCRIPTION; QUESTIONNAIRE;

EID: 78649303163     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/jgm.2010.23     Document Type: Article

References (33)

1. Australian Department of Health and Ageing. (1999) The National Medicines Policy 2000. Canberra, Australia: DoHA.
2. Sloan, C. (1995) A History of the Pharmaceutical Benefi ts Scheme 1947-1992. Canberra, Australia: Department of Human Service and Health.
3. Australian Department of Health and Ageing. (2008) Schedule of Pharmaceutical Benefi ts, Effective 1 July 2008-31 July 2008. Canberra, Australia: DoHA.
4. Australian Institute of Health and Welfare. (2008) Australia's Health 2008. Canberra, Australia: AIHW.
5. Australian Department of Health and Ageing. (2010) New PBS safety net thresholds, http://www6.health.gov.au/internet/main/publishing.nsf/Content/pbs- safetynet-changes, accessed 11 January 2010.
6. Australian Institute of Health and Welfare. (2008) Health Expenditure Australia 2006-07, Health and Welfare Expenditure Series no. 35. Cat. No. HWE 42. Canberra, Australia: AIHW.
7. McManus, P., Birkett, D., Dudley, J. and Stevens, A. (2001) Impact of the minimum pricing policy and introduction of brand (generic) substitution into the pharmaceutical benefi ts scheme in Australia. Pharmacoepidemiology and Drug Safety 10 (4): 295-300.
8. Lofgren, H. (2004) Generic drugs: International trends and policy developments in Australia. Australian Health Review 27 (1): 39-48.
9. Australian Department of Health and Ageing. (2007) Pharmaceutical Benefi ts Scheme (PBS) reform. Fact Sheet, 2 February, http://www.healthconnect.gov.au/ internet/main/publishing.nsf/Content/pbs- reform-02feb07.htm, accessed 3 May 2008.
10. Pharmaceutical Benefi ts Pricing Authority. (2008) Annual Report for the Year Ended 30 June 2008. Canberra, Australia: PBPA.
11. Harvey, K., Faunce, T., Lokuge, B. and Drahos, P. (2004) Will the Australia-United States free trade agreement undermine the pharmaceutical benefi ts scheme? Medical Journal of Australia 181 (5): 256-259.
12. Outterson, K. (2004) Free trade in pharmaceuticals. Medical Journal of Australia 181 (5): 260-261.
13. Outterson, K. (2005) Agony in the antipodes: The generic drug provisions of the Australia-USA free trade agreement. Journal of Generic Medicines 2 (4): 316-326.
14. Faunce, T. et al (2005) Assessing the impact of the Australia-United States Free Trade Agreement on Australia and global medicines policy. Globalization and Health 1: 15, doi:10.1186/1744-8603-1-15. (Pubitemid 44848703)
15. Searles, A. (2009) The PBS in a globalised world: Free trade and reference pricing. Australian Health Review 33 (2): 186-191.
16. Faunce, T., Bai, J. and Nguyen, D. (2010) Impact of the Australia-US Free Trade Agreement on Australian medicines regulation and prices. Journal of Generic Medicines 7 (1): 18-29.
17. Lofgren, H. (2007) Reshaping Australian drug policy: The dilemmas of generic medicines policy. Australia and New Zealand Health Policy 4: 11, doi:10.1186/1743-8462-4-11. (Pubitemid 46993298)
18. Australian Department of Health and Ageing. (2006) Strengthening your PBS-preparing for the future http://www.health.gov.au/internet/main/publishing. nsf/Content/Strengthening-your-PBS.htm, accessed 11 January 2010.
19. Beecroft, G. (2007) Generic drug policy in Australia: A community pharmacy perspective. Australia and New Zealand Health Policy 4: 7, doi:10.1186/1743-8462-4-7. (Pubitemid 46939472)
20. Bulfone, L. (2009) High prices for generics in Australia-More competition might help. Australian Health Review 33 (2): 200.
21. Hassali, M. A., Kong, D. C. M. and Stewart, K. (2005) Generic medicines: Perceptions of community pharmacists in Melbourne, Australia. Journal of Pharmaceutical Finance, Economics and Policy 14 (3): 27-45.
22. Green, S. B., Salkind, N J. and Akey, T. M. (2000) K independent-samples tests: The Kruskal-Wallis and the median tests. In: N. Roberts (ed.) Using SPSS for Windows: Analysing and Understanding Data, 2nd edn. New Jersey: Prentice-Hall, pp. 361-372.
23. Green, S. B., Salkind, N J. and Akey, T. M. (2000) Methods for controlling Type I Error across multiple hypothesis tests. In: N. Roberts (ed.) Using SPSS for Windows: Analysing and Understanding Data, 2nd edn. New Jersey: Prentice-Hall, pp. 395-396.
24. Simoens, S. and De Coster, S. (2006) Sustaining Generic Medicines Markets in Europe. Belgium: Research Centre for Pharmaceutical Care and Pharmaco-economics, Katholieke Universiteit Leuven.
25. Allenet, B. and Barry, H. (2003) Opinion and behaviour of pharmacists towards the substitution of branded drugs by generic drugs: survey of 1,000 French community pharmacists. Pharmacy World and Science 25 (5): 197-202.
26. Faunce, T. and Lofgren, H. (2007) Drug price reforms: The new F1-F2 bifurcation. Australian Prescriber 30 (6): 138-140.
27. Banahan, B. and Kolassa, E. (1994) Generic Substitution and Narrow Therapeutic Index Drugs: A National Survey of Retail and Hospital Pharmacies. Mississippi: The University of Mississippi.
28. Sansom, L. (1999) The Australian national medicinal drug policy. Journal of Quality in Clinical Practice 19 (1): 31-35.
29. Hirst, C. A. (1992) Government initiatives in the development of a pharmaceutical industry in Australia. Clinical and Experimental Pharmacology and Physiology 19 (1): 57-61.
30. Hassali, M. A., Kong, D. C. M. and Stewart, K. (2007) A comparison between senior medical students ' and pharmacy pre-registrants ' knowledge and perceptions of generic medicines. Medical Education 41 (7): 703-710.
31. Williams, A. E. and Chrystyn, H. (2007) Survey of pharmacists ' attitudes towards interchangeable use of dry powder inhalers. Pharmacy World and Science 29 (3): 221-227.
32. National Prescribing Service Limited. (2009) Generic medicines: Information & resources for consumers, http://www.nps.org.au/consumers/ medicines and health-topics/topics/generic-medicines?queries-topic-query= Generic%20medicin es, accessed 30 January 2009.
33. National Prescribing Service. (2008) Generic medicines are an equal choice, http://www.nps.org.au/consumers/campaigns/generic-medicines, accessed 30 January 2010.